Break pharma’s boundaries.
Rebuild US healthcare.

With more digital content and channels available to HCPs than ever before, choices have become overwhelming. It’s time to admit reach and frequency can no longer be your strategy for competitive advantage. You must develop a seamless customer experience. One where each salesforce interaction and marketing touchpoint are driven by value, creating real behavior change, and delivering your commercial objectives.

And remember, it’ll be the finer details that count.

Leverage trusted data, form actionable insights, pin-point gaps in the customer journey and solve them. Develop a comprehensive hybrid salesforce strategy to ensure that their deep customer knowledge can still be used to its full potential. De-silo internal functions to build a more cohesive environment that puts the HCP first. Create your new competitive advantage through effortless interactions, personalized customer journeys and deliver concise content that enhances the HCP-patient experience.

Leading speakers include:

The momentum of Medical Affairs has reached a tipping point. Patients and HCPs have rejected the old status quos, in their place demanding only value-driven interactions and content. It must be education-first, delivered when and where it’s needed, with readily available high-quality evidence on demand. For us to redefine these expectations, the growth of Medical Affairs has never been more needed.

It’s time to diversify and scale your digital capabilities. To refine your multichannel engagement strategies. To deliver high-quality real-world evidence. And to empower MSLs to thrive in the new healthcare landscape.

Reuters Events Pharma USA is the only conference that unites medical affairs leadership with decision-makers from across the entire business. Its where new collaborations are forged, best practises are shared, and medical affairs propels itself to the forefront of pharma’s transformation. Let’s redefine stakeholder expectation together.

Leading speakers include:

Even as the industry rallies behind medical innovation, from specialty care to vaccines, the healthcare system remains fatally flawed; out of pocket costs increase, health inequity perseveres, rebates intensify, while cost savings are not passed onto patients.

Even in the face of increased scrutiny and public pressure, it’s time we become the architects of a better system.

Find and partner with effective new business models that subvert gross-to-net pressure. Improve patient enrollment by finding the most important points in provider and patient journeys to enable service initiatives. Design more informed agreements for wider access to ensure medical innovation shines, not hides. Work with clinical to ensure target patient populations for re-imbursement are represented in study design.

Leading speakers include:

The balance of power in healthcare is moving. Patients are taking ownership of their care pathways, and so pharma’s priorities must shift in return. Internally, you must reprioritize workstreams and restructure functions to give room for patient authority to grow. Externally, you must educate with the intent to empower, and fight tides of misinformation together with patients as equal partners.

Failure to invest in trust-building and community-first engagement strategies will risk the relevance of your company and the improved outcomes of your patients.

Leading speakers include: